Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin
- 8 October 1994
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 344 (8928) , 1025-1026
- https://doi.org/10.1016/s0140-6736(94)91687-x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Emergence of vancomycin-resistant enterococci in New York CityThe Lancet, 1993
- In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organismsAntimicrobial Agents and Chemotherapy, 1993
- Pristinamycin for Enterococcus faecium resistant to vancomycin and gentamicinThe Lancet, 1992
- A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500Journal of Antimicrobial Chemotherapy, 1992
- Resistance of Enterococcus faecium to vancomycin and gentamicinThe Lancet, 1991